Kāmini Walia

2.9k total citations · 1 hit paper
86 papers, 1.4k citations indexed

About

Kāmini Walia is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology. According to data from OpenAlex, Kāmini Walia has authored 86 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Medicine, 36 papers in Applied Microbiology and Biotechnology and 24 papers in Endocrinology. Recurrent topics in Kāmini Walia's work include Antibiotic Resistance in Bacteria (51 papers), Antibiotic Use and Resistance (36 papers) and Vibrio bacteria research studies (13 papers). Kāmini Walia is often cited by papers focused on Antibiotic Resistance in Bacteria (51 papers), Antibiotic Use and Resistance (36 papers) and Vibrio bacteria research studies (13 papers). Kāmini Walia collaborates with scholars based in India, United States and Switzerland. Kāmini Walia's co-authors include Balaji Veeraraghavan, VC OHRI, Shalini Anandan, Purva Mathur, Pallab Ray, Arti Kapil, Sujatha Sistla, Jayaprakasam Madhumathi, V Ramasubramanian and Dhiviya Prabaa Muthuirulandi Sethuvel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BMJ.

In The Last Decade

Kāmini Walia

79 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance

2024 44 citations Kāmini Walia et al. profile →

Peers

Countries citing papers authored by Kāmini Walia

Since Specialization

Citations

This map shows the geographic impact of Kāmini Walia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kāmini Walia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kāmini Walia more than expected).

Fields of papers citing papers by Kāmini Walia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kāmini Walia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kāmini Walia. The network helps show where Kāmini Walia may publish in the future.

Co-authorship network of co-authors of Kāmini Walia

This figure shows the co-authorship network connecting the top 25 collaborators of Kāmini Walia. A scholar is included among the top collaborators of Kāmini Walia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kāmini Walia. Kāmini Walia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NAMS task force report on antimicrobial resistance 2025 ·Annals of the National Academy of Medical Sciences (India) ·Arunaloke Chakrabarti, Balaji Veeraraghavan, N.K. Bansal, Ram Gopalakrishnan, Pratima Gupta, Amita Jain, Pratibha Kale, Arti Kapil, Kashi Nath Prasad, Pallab Ray, Camila Rodrigues, Kāmini Walia	2
2	Genetic characteristics and diversity of PDC variants of Pseudomonas aeruginosa and its clinical relevance 2024 ·Infection Genetics and Evolution ·(unknown), (unknown), (unknown), Yamuna Devi Bakthavatchalam, Binesh Lal, Kāmini Walia, Balaji Veeraraghavan	3
3	In vitro activity of zidebactam/cefepime (WCK 5222), a β-lactam enhancer/ β-lactam combination against carbapenem- and colistin-resistant Klebsiella pneumoniae isolates 2024 ·Diagnostic Microbiology and Infectious Disease ·Yamuna Devi Bakthavatchalam, Chaitra Shankar, (unknown), (unknown), Purva Mathur, Vasant Nagvekar, (unknown), Kāmini Walia, Balaji Veeraraghavan	0
4	Point Prevalence Study (PPS) of Antibiotic Usage and Bacterial Culture Rate (BCR) among Secondary Care Hospitals of Small Cities in Central India: Consolidating Indian Evidence 2023 ·SHILAP Revista de lepidopterología ·Shweta Kumar, (unknown), (unknown), (unknown), Ayush Gupta, Tadepalli Karuna, (unknown), Manish Gupta, (unknown), (unknown), (unknown), S. K. Shrivastava, (unknown), (unknown), (unknown), (unknown), Kāmini Walia, (unknown)	4
5	Determination of potential combination of non‐β‐lactam, β‐lactam, and β‐lactamase inhibitors/β‐lactam enhancer against class D oxacillinases producing Acinetobacter baumannii: Evidence from in‐vitro, molecular docking and dynamics simulation 2023 ·Journal of Cellular Biochemistry ·(unknown), (unknown), (unknown), (unknown), D. Thirumal Kumar, Abi Manesh, Kāmini Walia, Balaji Veeraraghavan, C. George Priya Doss	2
6	Clinico–Epidemio-Microbiological Exploratory Review Among COVID-19 Patients with Secondary Infection in Central India 2022 ·Infection and Drug Resistance ·(unknown), Rahul Garg, Shweta Kumar, Gyanendra Singh, (unknown), (unknown), Abhijit Pakhare, Saurabh Saigal, (unknown), Rajnish Joshi, Kāmini Walia, Sagar Khadanga	2
7	Antimicrobial consumption in intensive care unit patients at level 1 trauma centre in India 2021 ·Indian Journal of Medical Microbiology ·(unknown), Deepak Gupta, Ashish Bindra, Anjan Trikha, (unknown), Rajesh Malhotra, Kāmini Walia, Purva Mathur	2
8	Phylogenetic and Evolutionary Analysis Reveals the Recent Dominance of Ciprofloxacin-Resistant Shigella sonnei and Local Persistence of S. flexneri Clones in India 2020 ·mSphere ·Dhiviya Prabaa Muthuirulandi Sethuvel, Ankur Mutreja, Agila Kumari Pragasam, Karthick Vasudevan, (unknown), Shalini Anandan, Joy Sarojini Michael, Kāmini Walia, Balaji Veeraraghavan	4
9	Colistin Susceptibility Testing of Gram-Negative Bacilli: Better Performance of Vitek2 System than E-Test Compared to Broth Microdilution Method as the Gold Standard Test 2020 ·Indian Journal of Medical Microbiology ·Surojit Das, (unknown), (unknown), (unknown), (unknown), Purva Mathur, Kāmini Walia, Sanjay Bhattacharya	6
10	The Importance of Intra- and Inter-Institutional Networks for Capacity Building in Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcription Polymerase Chain Reaction Services: Experience from an Oncology Centre in Eastern India 2020 ·Indian Journal of Medical Microbiology ·Deepak Kumar Mishra, Gaurav Goel, Neeraj Arora, Shekhar Krishnan, Sanjay Bhattacharya, Purva Mathur, Kāmini Walia, Mammen Chandy	2
11	Antimicrobial susceptibility profile & resistance mechanisms of Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens from India 2019 ·The Indian Journal of Medical Research ·Balaji Veeraraghavan, Kāmini Walia	40
12	Antimicrobial resistance, virulence & plasmid profiles among clinical isolates of Shigella serogroups 2019 ·The Indian Journal of Medical Research ·Dhiviya Prabaa Muthuirulandi Sethuvel, (unknown), Shalini Anandan, Joy Sarojini Michael, Naveen Kumar Devanga Ragupathi, (unknown), Kāmini Walia, Balaji Veeraraghavan	15
13	Understanding policy dilemmas around antibiotic use in food animals & offering potential solutions 2019 ·The Indian Journal of Medical Research ·Kāmini Walia, (unknown), (unknown), Bibek Ranjan Shome	43
14	Dominance of International High-Risk Clones in Carbapenemase-Producing Pseudomonas aeruginosa: Multicentric Molecular Epidemiology Report from India 2018 ·Indian Journal of Medical Microbiology ·Agila Kumari Pragasam, Balaji Veeraraghavan, Shalini Anandan, (unknown), Sujatha Sistla, Arti Kapil, Purva Mathur, Pallab Ray, Chand Wattal, Sanjay Bhattacharya, (unknown), Subramani Kandasamy, John Victor Peter, (unknown), (unknown), (unknown), Kāmini Walia, VC OHRI	27
15	Combating antimicrobial resistance in India 2017 ·The Indian Journal of Medical Research ·Rajesh Bhatia, Kāmini Walia	13
16	Using information technology to improve surveillance of antimicrobial resistance in South East Asia 2017 ·BMJ ·Sirenda Vong, (unknown), Anette Hulth, John Stelling, Visanu Thamlikitkul, Sunil Gupta, Jonas M. Fuks, Kāmini Walia, (unknown), Sergey Eremin, (unknown), Tika Sedai, (unknown)	17
17	First Indian report of IncX3 plasmid carrying bla NDM-7 in Escherichia coli from bloodstream infection: potential for rapid dissemination 2017 ·New Microbes and New Infections ·Naveen Kumar Devanga Ragupathi, Dhiviya Prabaa Muthuirulandi Sethuvel, (unknown), (unknown), Kāmini Walia, Balaji Veeraraghavan	16
18	First report of bla OXA-181 -mediated carbapenem resistance in Aeromonas caviae in association with pKP3-A: Threat for rapid dissemination 2017 ·Journal of Global Antimicrobial Resistance ·Shalini Anandan, (unknown), Naveen Kumar Devanga Ragupathi, Dhiviya Prabaa Muthuirulandi Sethuvel, (unknown), Kāmini Walia, Balaji Veeraraghavan	24
19	Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India 2016 ·Infectious Diseases and Therapy ·Saranya Vijayakumar, (unknown), (unknown), (unknown), Kāmini Walia, Shalini Anandan, Balaji Veeraraghavan	45
20	Potential impact of spouse's circumcision on herpes simplex virus type 2 prevalence among antenatal women in five northeastern states of India 2010 ·International Journal of Infectious Diseases ·(unknown), Dipankar Biswas, Kāmini Walia, Jagadish Mahanta	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact